We are live on ! Find out more
Profund Advisors

Profund Advisors Portfolio holdings

AUM $3.48B Turnover 14.37%
1-Year Est. Return 66.96%
 

ProFund Advisors manages the ProFunds mutual funds, which include index funds across sectors, bonds, currencies and crypto, as well as leveraged and inverse funds. The ProFunds brand dates from 1997, and its affiliate ProShares began offering leveraged and inverse ETFs in 2006. The Bitcoin ProFund tracks bitcoin futures rather than holding bitcoin itself.

This Fund
S&P 500
This Quarter Est. Return
+3.6%
1 Year Est. Return
+66.96%
3 Year Est. Return
+258.11%
5 Year Est. Return
+342.15%
10 Year Est. Return
+1,333.1%
AUM
$3.48B
AUM Growth
-$153M
Cap. Flow
-$155M
Cap. Flow %
-4.44%
Top 10 Hldgs %
41.36%
Holding
1,225
New
50
Increased
319
Reduced
729
Closed
126
Avg Time Held
6.2 years
Top 10 Avg Time Held
4.5 years
Top 20 Avg Time Held
5.7 years

Top Buys

Rank Stock Value
1
SPCX icon
SpaceX
SPCX
+$37.8M
2
ALMS icon
Alumis Inc
ALMS
+$2.98M
3
COLL icon
Collegium Pharmaceutical
COLL
+$1.65M
4
RDDT icon
Reddit
RDDT
+$1.57M
5
SEPN icon
Septerna Inc
SEPN
+$1.45M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$46.8M
2
AVGO icon
Broadcom
AVGO
+$15.2M
3
MU icon
Micron Technology
MU
+$13.3M
4
AAPL icon
Apple
AAPL
+$12.8M
5
AMD icon
Advanced Micro Devices
AMD
+$10.8M

Sector Composition

Rank Sector Weight
1 Technology 54.2%
2 Healthcare 10.88%
3 Communication Services 8.15%
4 Consumer Discretionary 7.38%
5 Industrials 4.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
RARE icon
326
Ultragenyx Pharmaceutical
RARE
$1.66B
$1.16M 0.03%
76,847
+25,397
+49% +$610K
2015 Q3
44 quarters
SPGI icon
327
S&P Global
SPGI
$136B
$1.15M 0.03%
2,912
+286
+11% +$121K
2016 Q2
41 quarters
ZTO icon
328
ZTO Express
ZTO
$15B
$1.14M 0.03%
58,895
+1,097
+2% +$24.4K
2017 Q2
37 quarters
ED icon
329
Consolidated Edison
ED
$44.3B
$1.13M 0.03%
11,089
-451
-4% -$48.9K
2013 Q2
53 quarters
PURR icon
330
Hyperliquid Strategies Inc
PURR
$1.74B
$1.13M 0.03%
91,907
+3,712
+4% +$34.7K
2026 Q1
2 quarters
EDU icon
331
New Oriental
EDU
$8.14B
$1.12M 0.03%
20,259
-238
-1% -$12.9K
2022 Q3
16 quarters
RAPP icon
332
Rapport Therapeutics
RAPP
$1.53B
$1.11M 0.03%
33,112
+26,754
+421% +$1.15M
2026 Q2
1 quarter
TTE icon
333
TotalEnergies
TTE
$196B
$1.11M 0.03%
13,001
+1,399
+12% +$121K
2013 Q2
53 quarters
IMVT icon
334
Immunovant
IMVT
$7.25B
$1.1M 0.03%
32,693
-3,817
-10% -$150K
2023 Q1
14 quarters
COF icon
335
Capital One
COF
$116B
$1.1M 0.03%
5,712
+497
+10% +$104K
2013 Q2
53 quarters
LBRX icon
336
LB Pharmaceuticals
LBRX
$1.37B
$1.08M 0.03%
+28,203
New +$1.17M
2026 Q3
0 quarters
MCK icon
337
McKesson
MCK
$124B
$1.08M 0.03%
1,266
-73
-5% -$62.8K
2013 Q2
53 quarters
DYN icon
338
Dyne Therapeutics
DYN
$3.19B
$1.08M 0.03%
67,005
+8,195
+14% +$188K
2023 Q2
13 quarters
AGI icon
339
Alamos Gold
AGI
$12B
$1.08M 0.03%
33,233
-220
-0.7% -$7.25K
2017 Q3
36 quarters
SLS icon
340
SELLAS Life Sciences
SLS
$1.62B
$1.07M 0.03%
87,289
-33,318
-28% -$417K
2026 Q1
2 quarters
SYK icon
341
Stryker
SYK
$119B
$1.07M 0.03%
3,899
-36
-0.9% -$11.3K
2013 Q2
53 quarters
SITM icon
342
SiTime
SITM
$14.2B
$1.07M 0.03%
1,640
+1,136
+225% +$689K
2025 Q2
5 quarters
WVE icon
343
Wave Life Sciences
WVE
$622M
$1.07M 0.03%
288,348
+240,754
+506% +$1.27M
2024 Q2
9 quarters
EQNR icon
344
Equinor
EQNR
$101B
$1.06M 0.03%
25,590
+2,754
+12% +$111K
2013 Q2
53 quarters
CB icon
345
Chubb
CB
$142B
$1.06M 0.03%
3,268
+246
+8% +$84.9K
2013 Q2
53 quarters
OCUL icon
346
Ocular Therapeutix
OCUL
$1.38B
$1.06M 0.03%
138,128
+104,927
+316% +$1.03M
2024 Q1
10 quarters
HPE icon
347
Hewlett Packard
HPE
$66.6B
$1.06M 0.03%
16,562
-2,052
-11% -$109K
2015 Q4
43 quarters
PH icon
348
Parker-Hannifin
PH
$121B
$1.05M 0.03%
1,102
-165
-13% -$162K
2015 Q4
43 quarters
RXRX icon
349
Recursion Pharmaceuticals
RXRX
$2.08B
$1.05M 0.03%
254,369
-54,728
-18% -$185K
2023 Q1
14 quarters
BNY icon
350
Bank of New York Mellon
BNY
$103B
$1.04M 0.03%
7,209
+461
+7% +$72.4K
2013 Q2
53 quarters
12 13
14
15 16

Similar funds

Tremblant Capital Group
Tremblant Capital Group West Palm Beach, Florida $3.48B AUM 29.32% 1-Year Est. Return
Stock Yards Bank & Trust
Stock Yards Bank & Trust Louisville, Kentucky $3.49B AUM 27.82% 1-Year Est. Return
Iconiq Capital
Iconiq Capital San Francisco, California $3.47B AUM 23.74% 1-Year Est. Return
TC
Torno Capital Cohasset, Massachusetts $3.47B AUM 37.88% 1-Year Est. Return
Cooperman Leon G
Cooperman Leon G $3.55B AUM 41.85% 1-Year Est. Return
SHIM
Spruce House Investment Management New York $3.4B AUM 30.65% 1-Year Est. Return
Voyager Global Management
Voyager Global Management New York $3.63B AUM 5.73% 1-Year Est. Return
Needham Investment Management
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return

Profund Advisors's Q3 2026 Portfolio in Review

As of Q3 2026, Profund Advisors held 1,225 positions worth $3.48B, down 4.2% from $3.64B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Profund Advisors withdrew a net $155M in Q3 2026, closing 126 positions and reducing 729 holdings. Its most notable exit was Electronic Arts, an estimated $5.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 54% of assets, down from 56% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Profund Advisors opened a new position in SpaceX worth $41.3M.

  • Profund Advisors's largest Q3 2026 buy was SpaceX: 273,453 shares worth $41.3M.
  • Profund Advisors added most to Alumis Inc in Q3 2026, an estimated $2.98M increase.
  • Profund Advisors's biggest Q3 2026 reduction was NVIDIA, cutting an estimated $46.8M.
  • Profund Advisors fully exited Electronic Arts in Q3 2026, selling an estimated $5.2M.
  • Profund Advisors's ten largest holdings make up 41% of its $3.48B portfolio in Q3 2026.
  • Profund Advisors opened 50 new positions and closed 126 in Q3 2026.
  • Profund Advisors's portfolio value fell 4.2% quarter-over-quarter to $3.48B.

Based on Profund Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.